TipRanks
Go Ultimate55% OFF

Lemonade (0A91) Risk Analysis

Public companies are required to disclose risks that can affect the business and impact the stock. These disclosures are known as “Risk Factors”. Companies disclose these risks in their yearly (Form 10-K), quarterly earnings (Form 10-Q), or “foreign private issuer” reports (Form 20-F). Risk factors show the challenges a company faces. Investors can consider the worst-case scenarios before making an investment. TipRanks’ Risk Analysis categorizes risks based on proprietary classification algorithms and machine learning. Lemonade disclosed 68 risk factors in its most recent earnings report. Lemonade reported the most risks in the “Finance & Corporate” category.

Risk Overview Q2, 2026

Source: the company's latest filing for the period ended Jun 30, 2026, filed Aug 04, 2026

Risk Distribution
68Risks
Sector Avg.Finance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Risk Change Over Time

Lemonade disclosed risks per quarterNo. of Risks60708090100110Q3Q4Q12023Q4Q12024Q3Q4Q2Q4Q12026Q2Showing: Q4, 2025
Risks removedRisks addedRisks changedLemonade Risk Factors
Loading…

Risk Highlights Q2, 2026

Main Risk Category
Finance & Corporate
With 23 Risks
Number of Disclosed Risks
68
No changes from last report
S&P 500 Average: 32
Recent Changes
0Risks added
0Risks removed
0Risks changed
Since Jun 2026
Number of Risk Changed
0
No changes from last report
S&P 500 Average: 1

Risk Word Cloud

we may not be able to utilize our net operating loss carryforwards ("nols") to offset future taxable income for u.s. federal income tax purposes, which could adversely affect our net income and cash flows.adversely affect our net incomeperformance of our investment portfolio is subject to a variety of investment risks that may adversely affect our financial results.performance of our investment portfoliowe are subject to payment processing risk.subject to payment processing riskwe employ third-party licensed software for use in our business, and the inability to maintain these licenses, errors in the software we license or the terms of open source licenses could result in increased costs or reduced service levels, which would adversely affect our business.employ third-party licensed softwarewe rely on the experience and expertise of our co-founders, senior management team, highly-specialized insurance experts, key technical employees and other highly skilled personnel.expertise of our co-foundersif securities or industry analysts cease publishing research or reports about us, our business or our markets, or if they adversely change their recommendations or publish negative reports regarding our business or our stock, our stock price and trading volume could materially decline.industry analysts cease publishing researchif our customers were to claim that the policies they purchased failed to provide adequate or appropriate coverage, we could face claims that could harm our business, results of operations and financial condition.purchased failed to provide adequatewe may not be able to utilize our net operating loss carryforwards ("nols") to offset future taxable income for u.s. federal income tax purposes, which could adversely affect our net income and cash flows.to offset future taxable incomewe may be subject to compliance obligations arising from medical information privacy regulations.subject to compliance obligations arisingour exposure to loss activity and regulation may be greater in states where we currently have most of our customers: california, new york and texas.our exposure to loss activity

Risk Factors Full Breakdown - Total Risks 68

Share Price & Shareholder Rights7 | 10.3%
  • Share Price & Shareholder Rights - Risk 1
    Our status as a Delaware public benefit corporation and a Certified B Corp may negatively impact our financial performance, limit stockholder influence, and subject us to increased litigation.

    As a public benefit corporation (PBC) we are legally required to operate in a responsible and sustainable manner, balancing the financial interests of our stockholders with the best interests of those materially affected by our conduct and the specific public benefits identified in our Amended Charter. To retain our B Corp certification we must meet high standards of verified performance, accountability, and transparency set by B Lab. This unique structure introduces several significant risks: - Conflict of Fiduciary Duties: Unlike traditional corporations that focus exclusively on maximizing stockholder value, our directors have a fiduciary duty to consider our specific public benefit and other stakeholders. Consequently, we may take actions that we believe serve our public benefit purpose even if they do not maximize financial results or distributions to stockholders. There is no guarantee that conflicts between stockholder interests and our public benefit goals will be resolved in favor of stockholders. - Reputational and Certification Risks: Our brand relies on the credibility and trust built through our Certified B Corp status. If we lose this certification, or if our publicly reported B Corp score declines, it may create a perception that we are no longer committed to our values, harming our reputation and business. Furthermore, we must publicly disclose a biennial report on our public benefit performance; any failure to provide this report or a negative perception of its contents could damage our status. - Reduced Attractiveness for Takeovers and Activism: Our PBC status makes us a less attractive target for acquisitions and activist investors. Delaware law requires a two-thirds vote to merge with an entity that does not contain identical public benefit provisions. Additionally, the requirement for directors to consider multiple constituencies may make it easier for the board to reject hostile bids that might otherwise provide a short-term financial yield to stockholders. - Derivative Litigation Exposure: Stockholders owning at least 2% of our shares may file derivative lawsuits claiming our directors failed to balance stockholder and public benefit interests-a liability that does not exist for traditional corporations. Such litigation could be costly and divert management's attention from executing our business strategy. - Regulatory Interference with Charitable Contributions: State or federal regulators could restrict or delay our ability to donate residual premiums to customer-selected nonprofits through our Giveback program. Any such interference could erode customer trust, weaken incentives for good customer behavior, and adversely affect demand for our products. Any failure to achieve our public benefit purpose or maintain our certifications could have a material adverse effect on our reputation, business, results of operations, and stock price.

  • Share Price & Shareholder Rights - Risk 2
    The market price of our common stock may be volatile or decline, and you may not be able to resell your shares at or above the price you initially paid for our common stock.

    The trading price of our common stock could be volatile, and you could lose all or part of your investment. The following factors, in addition to other factors described in this "Risk Factors" section and included elsewhere in this document may have a significant impact on the market price of our common stock: - the occurrence of severe weather conditions and other catastrophes;- our operating and financial performance, quarterly or annual earnings relative to similar companies;- publication of research reports or news stories about us, our competitors or our industry, or positive or negative recommendations or withdrawal of research coverage by securities analysts;- the public's reaction to our press releases, our other public announcements and our filings with the SEC;- announcements by us or our competitors of acquisitions, business plans or commercial relationships;- any major change in our board of directors or senior management, including the departure of either of our Co-Founders;- additional sales of our common stock by us, our directors, executive officers, principal shareholders, or our Co-Founders;- adverse market reaction to any indebtedness we may incur or securities we may issue in the future;- short sales, hedging and other derivative transactions in our common stock;- exposure to capital market risks related to changes in interest rates, realized investment losses, credit spreads, equity prices, foreign exchange rates and performance of insurance- linked investments;- our creditworthiness, financial condition, performance, and prospects;- our dividend policy and whether dividends on our common stock have been, and are likely to be, declared and paid from time to time;- perceptions of the investment opportunity associated with our common stock relative to other investment alternatives;- regulatory or legal developments;- changes in general market, economic, and political conditions;- conditions or trends in our industry, geographies or customers;- short selling activities - changes in accounting standards, policies, guidance, interpretations or principles; and - threatened or actual litigation or government investigations. In addition, broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating performance, and factors beyond our control may cause our stock price to decline rapidly and unexpectedly. In addition, in the past, companies that have experienced volatility in the market price of their stock have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Litigation of this type could result in substantial costs and diversion of management's attention and resources, which could have a material adverse effect on our business, financial condition, results of operations or prospects. Any adverse determination in litigation could also subject us to significant liabilities.

  • Share Price & Shareholder Rights - Risk 3
    Some provisions of our charter documents and Delaware law may have anti-takeover effects that could discourage an acquisition of us by others, even if an acquisition would be beneficial to our stockholders, and may prevent attempts by our stockholders to replace or remove our current management.

    Provisions in our Amended Charter and our Amended Bylaws, as well as provisions of the Delaware General Corporation Law (the "DGCL"), could make it more difficult for a third party to acquire us or increase the cost of acquiring us, even if doing so would benefit our stockholders, including transactions in which stockholders might otherwise receive a premium for their shares. These provisions include: - our board of directors is classified into three classes of directors with staggered three-year terms and directors are only able to be removed from office for cause;- nothing in our Amended Charter precludes future issuances without stockholder approval of the authorized but unissued shares of our common stock;- advance notice procedures apply for stockholders to nominate candidates for election as directors or to bring matters before an annual meeting of stockholders;- our stockholders will only be able to take action at a meeting of stockholders and not by written consent;- only our chairman of the board of directors, our chief executive officer, our president (in the absence of the chief executive officer), or a majority of the board of directors are authorized to call a special meeting of stockholders;- no provision in our Amended Charter or Amended Bylaws provides for cumulative voting, which limits the ability of minority stockholders to elect director candidates;- directors will only be able to be removed for cause;- certain amendments to our Amended Charter will require the approval of two-thirds of the then outstanding voting power of our capital stock;- our Amended Bylaws will provide that the affirmative vote of two-thirds of the then-outstanding voting power of our capital stock, voting as a single class, is required for stockholders to amend or adopt any provision of our bylaws;- our Amended Charter authorizes undesignated preferred stock, the terms of which may be established and shares of which may be issued, without the approval of the holders of our capital stock; and - certain litigation against us can only be brought in Delaware. These anti-takeover defenses could discourage, delay or prevent a transaction involving a change in control of our Company. These provisions could also discourage proxy contests and make it more difficult for you and other stockholders to elect directors of your choosing and cause us to take corporate actions other than those you desire.

  • Share Price & Shareholder Rights - Risk 4
    Applicable insurance laws may make it difficult to effect a change of control.

    Under applicable state insurance laws and regulations, no person may acquire control of a domestic insurer until written approval is obtained from the state insurance commissioner following a public hearing on the proposed acquisition. Such approval would be contingent upon the state insurance commissioner's consideration of a number of factors including, among others, the financial strength of the proposed acquiror, the acquiror's plans for the future operations of the domestic insurer and any anti- competitive results that may arise from the consummation of the acquisition of control. LIC is domiciled in New York and MIC is domiciled in Delaware. Per the applicable laws and regulations of New York and Delaware, respectively, generally no person may acquire control of any insurer, whether by purchase of its securities or otherwise, unless it gives prior notice to the insurer and has received prior approval from the superintendent or Commissioner of Financial Services. Under New York and Delaware insurance law, an entity is presumed to have control of an insurance company if it owns, directly or indirectly, 10% or more of the voting stock of that insurance company or its parent company. These requirements may discourage potential acquisition proposals and may delay, deter, or prevent a change of control of Lemonade, Inc., including through transactions that some or all of the stockholders might consider to be desirable.

  • Share Price & Shareholder Rights - Risk 5
    Our Amended Charter designates the Court of Chancery of the State of Delaware as the exclusive forum for certain litigation that may be initiated by our stockholders, which could limit our stockholders' ability to obtain a favorable judicial forum for disputes with us.

    Our Amended Charter provides that the Court of Chancery of the State of Delaware will be the sole and exclusive forum for (i) any derivative action or proceeding brought on our behalf, (ii) any action asserting a claim of breach of a fiduciary duty owed to us or our stockholders by any of our directors, officers, employees or agents, (iii) any action asserting a claim against us arising under the DGCL or (iv) any action asserting a claim against us that is governed by the internal affairs doctrine; provided that, the exclusive forum provision will not apply to suits brought to enforce any liability or duty created by the Securities Act or the Exchange Act, or to any claim for which the federal courts have exclusive jurisdiction. By becoming a stockholder in the Company, you will be deemed to have notice of and have consented to the provisions of our Amended Charter related to choice of forum. The choice of forum provision in our Amended Charter may limit our stockholders' ability to obtain a favorable judicial forum for disputes with us. Additionally, the enforceability of choice of forum provisions in other companies' governing documents has been challenged in legal proceedings, and it is possible that, in connection with any applicable action brought against us, a court could find the choice of forum provisions contained in our Amended Charter to be inapplicable or unenforceable in such action. If so, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, results of operations, and financial condition.

  • Share Price & Shareholder Rights - Risk 6
    An active, liquid trading market for our common stock may not be sustained, which may cause our common stock to trade at a discount from the public offering price and make it difficult for you to sell the common stock you purchase.

    We cannot predict the extent to which investor interest in us will sustain a trading market on the NYSE or how active and liquid that market may remain. If an active and liquid trading market is not sustained, you may have difficulty selling any of our common stock that you purchase at a price above the price you purchase it or at all. The failure of an active and liquid trading market to continue would likely have a material adverse effect on the value of our common stock. The market price of our common stock may decline below the public offering price, and you may not be able to sell your shares of our common stock at or above the price you paid or at all. An inactive market may also impair our ability to raise capital to continue to fund operations by selling shares and may impair our ability to acquire other companies or technologies by using our shares as consideration.

  • Share Price & Shareholder Rights - Risk 7
    If securities or industry analysts cease publishing research or reports about us, our business or our markets, or if they adversely change their recommendations or publish negative reports regarding our business or our stock, our stock price and trading volume could materially decline.

    The trading market for our common stock will be influenced by the research and reports that industry or securities analysts may publish about us, our business, our markets, or our competitors. Analysts may not continue to cover us or provide favorable coverage. If any of the analysts who may cover us adversely change their recommendation regarding our stock, or provide more favorable relative recommendations about our competitors, our stock price could materially decline. If any analyst who may cover us were to cease coverage of the Company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to materially decline.

See a full breakdown of risk according to category and subcategory. The list starts with the category with the most risk. Click on subcategories to read relevant extracts from the most recent report.

FAQ

What are “Risk Factors”?
Risk factors are any situations or occurrences that could make investing in a company risky. The Securities and Exchange Commission (SEC) requires that publicly traded companies disclose their most significant risk factors. This is so that potential investors can consider any risks before they make an investment. They also offer companies protection, as a company can use risk factors as liability protection. This could happen if a company underperforms and investors take legal action as a result. It is worth noting that smaller companies, that is those with a public float of under $75 million on the last business day, do not have to include risk factors in their 10-K and 10-Q forms, although some may choose to do so.
How do companies disclose their risk factors?
Publicly traded companies initially disclose their risk factors to the SEC through their S-1 filings as part of the IPO process. Additionally, companies must provide a complete list of risk factors in their Annual Reports (Form 10-K) or (Form 20-F) for “foreign private issuers”. Quarterly Reports also include a section on risk factors (Form 10-Q) where companies are only required to update any changes since the previous report. According to the SEC, risk factors should be reported concisely, logically and in “plain English” so investors can understand them.
How can I use TipRanks risk factors in my stock research?
Use the Risk Factors tab to get data about the risk factors of any company in which you are considering investing. You can easily see the most significant risks a company is facing. Additionally, you can find out which risk factors a company has added, removed or adjusted since its previous disclosure. You can also see how a company’s risk factors compare to others in its sector. Without reading company reports or participating in conference calls, you would most likely not have access to this sort of information, which is usually not included in press releases or other public announcements. A simplified analysis of risk factors is unique to TipRanks.
What are all the risk factor categories?
TipRanks has identified 6 major categories of risk factors and a number of subcategories for each. You can see how these categories are broken down in the list below. 1. Financial & Corporate Accounting & Financial Operations - risks related to accounting loss, value of intangible assets, financial statements, value of intangible assets, financial reporting, estimates, guidance, company profitability, dividends, fluctuating results. Share Price & Shareholder Rights – risks related to things that impact share prices and the rights of shareholders, including analyst ratings, major shareholder activity, trade volatility, liquidity of shares, anti-takeover provisions, international listing, dual listing. Debt & Financing – risks related to debt, funding, financing and interest rates, financial investments. Corporate Activity and Growth – risks related to restructuring, M&As, joint ventures, execution of corporate strategy, strategic alliances. 2. Legal & Regulatory Litigation and Legal Liabilities – risks related to litigation/ lawsuits against the company. Regulation – risks related to compliance, GDPR, and new legislation. Environmental / Social – risks related to environmental regulation and to data privacy. Taxation & Government Incentives – risks related to taxation and changes in government incentives. 3. Production Costs – risks related to costs of production including commodity prices, future contracts, inventory. Supply Chain – risks related to the company’s suppliers. Manufacturing – risks related to the company’s manufacturing process including product quality and product recalls. Human Capital – risks related to recruitment, training and retention of key employees, employee relationships & unions labor disputes, pension, and post retirement benefits, medical, health and welfare benefits, employee misconduct, employee litigation. 4. Technology & Innovation Innovation / R&D – risks related to innovation and new product development. Technology – risks related to the company’s reliance on technology. Cyber Security – risks related to securing the company’s digital assets and from cyber attacks. Trade Secrets & Patents – risks related to the company’s ability to protect its intellectual property and to infringement claims against the company as well as piracy and unlicensed copying. 5. Ability to Sell Demand – risks related to the demand of the company’s goods and services including seasonality, reliance on key customers. Competition – risks related to the company’s competition including substitutes. Sales & Marketing – risks related to sales, marketing, and distribution channels, pricing, and market penetration. Brand & Reputation – risks related to the company’s brand and reputation. 6. Macro & Political Economy & Political Environment – risks related to changes in economic and political conditions. Natural and Human Disruptions – risks related to catastrophes, floods, storms, terror, earthquakes, coronavirus pandemic/COVID-19. International Operations – risks related to the global nature of the company. Capital Markets – risks related to exchange rates and trade, cryptocurrency.